Baxter Sigma and Spectrum IQ Infusion Systems

2021 ◽  
Vol 51 (2) ◽  
pp. 9-11
Keyword(s):  
2017 ◽  
Vol 2 (2) ◽  
Author(s):  
Roland A. Snijder ◽  
Maurits K. Konings ◽  
Agnes van den Hoogen ◽  
Annemoon M.D.E. Timmerman

AbstractIntroductionInfusion therapy is challenging and dosing errors may occur due to physical phenomena related to the infusion hardware, despite the use of accurate syringe pumps. These errors typically occur after interventions, such as the exchange of a syringe. We aimed to characterize and quantify dosing errors due to a syringe exchange in relation to physical properties of infusion hardware.MethodsAn analytical simulation model was used to investigate dosing errors due to two different syringe exchange protocols (variations). Each protocol involved a fast syringe pump, containing a non-critical medication, and a slow syringe pump, containing a critical drug. The protocols were also reproduced inResultsThe syringe exchange of the slow pump resulted in an additional delay of up to 3536 seconds due to backflow. Syringe exchange of the fast pump resulted in an undiluted volume of critical drug (0.17 ml) accumulated in the infusion system, which may result in a dosing error rate of 2400 %. The quantity of the dosing errors are related to the syringe exchange duration; however, impact of infusion hardware properties is generally larger. Smaller syringes, catheters with larger diameters and less compliant infusion systems in general give rise to smaller dosing errors during a syringe exchange. If both lines are clamped, additional dosing errors can be prevented.ConclusionInfusion hardware has a substantial impact on the dosing errors during a syringe exchange. Clamping or blocking the infusion lines using, e. g. stopcocks, on all infusion lines during a syringe exchange is essential.


2000 ◽  
Vol 93 (3A) ◽  
pp. A-570
Author(s):  
Thomas A. Neff ◽  
Gabriele Schulz ◽  
Joachim Fischer ◽  
Oskar Baenziger ◽  
Markus Weiss

2007 ◽  
Vol 64 (2) ◽  
pp. 286 ◽  
Author(s):  
Stephen Knox ◽  
Richard P. Atkinson ◽  
Roger Stephens ◽  
Robert J. Coffey ◽  
Edie E. Zusman

2005 ◽  
Vol 18 (4) ◽  
pp. 791-798 ◽  
Author(s):  
R. Anacardio ◽  
S. Bartolini ◽  
M.M. Gentile ◽  
M. Bagnasco ◽  
G. Carlucci

Ketoprofen lysine salt (Artrosilene®, injectable solution) is a non-steroidal anti-inflammatory agent frequently administered by slow intravenous infusion with portable elastomeric infusion systems in association regimen with other analgesic drugs. The aim of this study was to investigate the physicochemical compatibility between ketoprofen lysine salt (Artrosilene®, injectable solution) and other injectable drugs frequently used in association, such as tramadol hydrochloride, keterolac tromethamine and morphine hydrochloride, into the Infusor LV5, Baxter elastomeric infusion system. Physicochemical properties of drug mixture, including colour, clarity, pH and drug content were observed or measured by a reversed-phase HPLC method with UV detection, before and after (up to 7 days) mixing at room temperature and under light protection. The results obtained demonstrated the physicochemical compatibility of ketoprofen lysine salt (Artrosilene®, injectable solution) with all drug formulations at every tested mixing ratios into Baxer Infusor LV5 infusion devices.


Author(s):  
Marcela Padilha Facetto Azevedo ◽  
Rachel Maciel Monteiro ◽  
Ana Maria Razaboni ◽  
Denise De Andrade ◽  
Evandro Watanabe

Sign in / Sign up

Export Citation Format

Share Document